Mirae Asset Global Investments Co., Ltd. Bristol Myers Squibb CO Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,118,317 shares of BMY stock, worth $97.4 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
2,118,317
Previous 1,664,157
27.29%
Holding current value
$97.4 Million
Previous $101 Million
3.39%
% of portfolio
0.35%
Previous 0.27%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,730Shares Held
1.59BCall Options Held
26MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.8 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.3 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.06 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.8B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...